Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted November 20, 2013
Three Sexual Enhancement Supplements Recalled
Desmethylcarbondenafil is a phosphodiesterase PDE-5 inhibitor, a class of drugs used to treat erectile dysfunction. This drug can cause symptoms like headache and flushing, and can interact with medications containing nitrates such as nitroglycerine, resulting in dangerously low blood pressure.
Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) that does not have FDA approval.
Recalled Rhino 5 Plus, Maxtremezen, and Extenzone are packaged in one-capsule blister packs, and were distributed to retail customers in California by Jobbers Wholesale from June 1, 2013 to November 7, 2013. They can be identified by the following lot numbers:
- Rhino 5 Plus, Lot No. KWAKPMC030505175957019
- Maxtremezen, Lot No. JBP-L-1270-70
- Extenzone, Lot No. KWAKPMC03050517
Consumers who have purchased these supplements should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.
See ConsumerLab.com's Review of Sexual Enhancement Supplements for tests of related products.
See Related Warnings:
For more details about this recall, use the link below.